| [1] | Nakagawara A, Li YY, Izumi H, et al. Neuroblastoma. Jpn J Clin Oncol, 2018; 48, 214−41. doi: 10.1093/jjco/hyx176 | 
| [2] | Michaelis J, Haaf HG, Zöllner J, et al. Case control study of neuroblastoma in west-Germany after the Chernobyl accident. Klin Padiatr, 1996; 208, 172−8. doi: 10.1055/s-2008-1046469 | 
| [3] | Guo SY, Zhang B, Qi W, et al. Role of estrogen receptor alpha in MEHP-induced proliferation and invasion of SH-SY5Y cells. Toxicology, 2021; 453, 152734. doi: 10.1016/j.tox.2021.152734 | 
| [4] | Su DQ, Jiang BB, Yang Y, et al. Effect of huaier on melanoma invasion, metastasis, and angiogenesis. Biomed Res Int, 2020; 2020, 8163839. | 
| [5] | Lammens T, Swerts K, Derycke L, et al. N-cadherin in neuroblastoma disease: expression and clinical significance. PLoS One, 2012; 7, e31206. doi: 10.1371/journal.pone.0031206 | 
| [6] | Walton JD, Kattan DR, Thomas SK, et al. Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia, 2004; 6, 838−45. doi: 10.1593/neo.04310 | 
| [7] | Kim JH. Di(2-ethylhexyl) phthalate promotes lung cancer cell line A549 progression via Wnt/β-catenin signaling. J Toxicol Sci, 2019; 44, 237−44. doi: 10.2131/jts.44.237 | 
| [8] | Papadas A, Asimakopoulos F. Versican in the tumor microenvironment. Adv Exp Med Biol, 2020; 1272, 55−72. | 
| [9] | Gheytanchi E, Mehrazma M, Madjd Z. Expression of Ki-67, p53 and VEGF in pediatric neuroblastoma. Asian Pac J Cancer Prev, 2014; 15, 3065−70. doi: 10.7314/APJCP.2014.15.7.3065 | 
| [10] | Hernández AJA, Reyes VL, Albores-García D, et al. MeHg affects the activation of FAK, Src, Rac1 and Cdc42, critical proteins for cell movement in PDGF-stimulated SH-SY5Y neuroblastoma cells. Toxicology, 2018; 394, 35−44. doi: 10.1016/j.tox.2017.11.019 |